On Air with Immunocine: Matt Halpert Joins Dr. Axe to Discuss Why Cancer Deaths Have Almost Doubled Since 1990
In a recent episode of the Dr. Josh Axe Show, Dr. Halpert sheds light on the alarming increase in global cancer deaths since 1990. They discuss reasons why conventional treatments like chemotherapy and radiation may not always be the best options for patients.
“I cannot justify any reason why you wouldn’t want to get your immune system in the game. You have Michael Jordan on your team, and you have him sitting on the bench.” -Dr. Halpert
This episode highlights the promise of immunotherapy – particularly the personalized Immunocine Dendritic Cell Treatment (IDCT), which is currently undergoing clinical trials, including a FDA “Fast Track” designation for glioblastoma.
READ THIS NEXT
Learning How to Fight Cancer Ep. 3: Dr. Stephen Noga on the Future of Dendritic Cell Therapy
In Episode 3 of Learning How to Fight Cancer, Matt Halpert sits down with Dr. Stephen Noga — a respected oncologist, immunologist, and for
Read More
The Checkpoint Inhibitor Revolution: Why the First Trials Changed Everything
In March 2011, the FDA approved a drug that would fundamentally change our understanding of cancer treatment forever. Ipilimumab (Yervoy), t
Read More
On Air with Immunocine: Matt Halpert Joins Heal Navigator to Discuss How the IDCT is Changing Lives Today
https://www.youtube.com/watch?v=SnFprB1I_K8&list=PLCaoz22dM92-Co9qqZESVpw-GNUdB0MV9 Listen to this Episode on Apple Podcasts Listen to
Read More
